Magnetic Resonance With Gadoxetic Acid for the Diagnosis of Hepatocellular Carcinoma in Patients With Liver Cirrhosis. Evaluation of Its Impact for the Non-invasive Diagnosis

Inclusion Criteria:

* more than 18 years old
* patient with diagnosis of liver cirrhosis Child Pugh A-B
* Patients without previous hepatocellular carcinoma in whom ultrasound detects a suspicious hepatic lesion; solitary solid and well-defined nodule between 10 and 20mm
* patients in whom diagnosis of hepatocellular carcinoma is a clinical need prior to treatment indication
* patient that agree to participate signing informed consent form

Exclusion Criteria:

* Patients with poor liver function who would have undergone transplantation even without hepatocellular carcinoma diagnosis (Child-Pugh C)
* patients with previous diagnosis of hepatocellular carcinoma
* patients with significant comorbidities that could prevent the optimum therapeutic decision in case of positive diagnosis of hepatocellular carcinoma
* patients with severe clotting alterations that contraindicate the fine-needle biopsy -Patients with chronic kidney disease or glomerular filtration rate \< 30 ml/min
* patients with contraindications to perform magnetic resonance imaging (pacemaker, claustrophobia...)
* Known hypersensitivity to study drugs or excipients
* pregnancy or breastfeeding